<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 74-year-old woman was treated by <z:chebi fb="0" ids="6504">lithium carbonate</z:chebi> 3 x 300 mg per day for drug-induced <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>After 8 days, she suddenly developed severe impairment of consciousness with myoclonias and <z:hpo ids='HP_0001276'>hypertonia</z:hpo> which persisted during 10 days despite <z:chebi fb="32" ids="30145">lithium</z:chebi> withdrawal and <z:chebi fb="40" ids="26710">sodium chloride</z:chebi> infusion </plain></SENT>
<SENT sid="2" pm="."><plain>Slight disorders of water and electrolyte metabolism, mild <z:hpo ids='HP_0000083'>renal failure</z:hpo> and the patient's age could have contributed to the development of intoxication </plain></SENT>
<SENT sid="3" pm="."><plain>Short-term <z:chebi fb="32" ids="30145">lithium</z:chebi> administration may be life-threatening and should thus be prescribed cautiously in <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> as in other conditions </plain></SENT>
</text></document>